Maravai LifeSciences Holdings, Inc.
MRVI
$7.38
$0.081.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 51.44M | 65.84M | 49.87M | 41.63M | 47.40M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 51.44M | 65.84M | 49.87M | 41.63M | 47.40M |
| Cost of Revenue | 30.79M | 32.14M | 35.32M | 35.98M | 39.63M |
| Gross Profit | 20.65M | 33.70M | 14.54M | 5.66M | 7.77M |
| SG&A Expenses | 32.07M | 29.09M | 30.38M | 35.40M | 37.66M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 66.56M | 65.12M | 69.50M | 75.22M | 82.17M |
| Operating Income | -15.12M | 720.00K | -19.63M | -33.59M | -34.78M |
| Income Before Tax | -21.80M | -6.53M | -63.01M | -45.15M | -74.13M |
| Income Tax Expenses | -171.00K | -151.00K | 6.00K | -92.00K | -4.29M |
| Earnings from Continuing Operations | -21.63M | -6.38M | -63.02M | -45.06M | -69.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 9.22M | 2.64M | 27.33M | 19.50M | 30.25M |
| Net Income | -12.42M | -3.73M | -35.68M | -25.56M | -39.59M |
| EBIT | -15.12M | 720.00K | -19.63M | -33.59M | -34.78M |
| EBITDA | -3.34M | 12.09M | -7.18M | -20.40M | -21.62M |
| EPS Basic | -0.08 | -0.03 | -0.25 | -0.18 | -0.27 |
| Normalized Basic EPS | -0.02 | 0.00 | 0.09 | -0.03 | 0.03 |
| EPS Diluted | -0.08 | -0.03 | -0.25 | -0.18 | -0.27 |
| Normalized Diluted EPS | -0.02 | 0.00 | 0.09 | -0.03 | 0.03 |
| Average Basic Shares Outstanding | 148.00M | 146.43M | 145.07M | 144.68M | 144.24M |
| Average Diluted Shares Outstanding | 148.00M | 146.43M | 145.07M | 144.68M | 144.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |